Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

About this update from Organogenesis Holdings Inc.

CANTON, Mass. , Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health , Life Science and Diagnostic Tools Conference , which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th . Management will participate in 1x1 meetings on Wednesday, February 14th . There will be no formal presentation. About Organogenesis Holdings Inc. Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com . Investor Inquiries: ICR Westwicke Mike Piccinino , CFA [email protected] Press and Media Inquiries: Organogenesis [email protected] Source: Organogenesis Holdings Inc.

View stock analysis, news, and events for Organogenesis Holdings Inc.